Typographic treatment saying 100M

Countless researchers. 100 million cells. 1 shared vision.

763322000

Final count of cells pledged! Still interested in QuantumScale? Submit below.

Decorative image of scientists working in a lab

Thank you for being a part of the 100M cell challenge!

We are pleased to announce the projects selected for the full subsidy:

  • Federico Gaiti, University Health Network, Elucidating molecular dependencies of glioblastoma cells engaged in neuronal crosstalk
  • Caleb Webber, UK Dementia Research Institute, Zebrafish whole brain disease modeling
  • Sophia George, University of Miami, African Caribbean Single Cell Network
  • Kevin Matthew Byrd, Virginia Commonwealth University, Mapping the pediatric inhalation interface at single cell resolution
  • David van Heel, Genes & Health / Queen Mary University of London, Genes & Health, multiomics
  • Tom Taghon, Department of Diagnostic Sciences, Faculty of Medicine and Health Sciences, Ghent University, Molecular drivers of human T cell development
  • Drew Neavin, Garvan Institute of Medical Research, Identifying patients at risk of drug-induced cardiotoxicity
  • Luis Barreiro, University of Chicago, Unveiling immune variation across diverse human populations
  • Barbara Treutlein, ETH Zurich, Predictive modeling of cell state-specific responses to small molecule perturbations in human organoids
  • Zack Lewis, Allen Institute for Brain Science, Sympathetic nervous system atlas
  • John Tsang, Yale University/Chan Zuckerberg Biohub New York, Deciphering the immune health of global populations
  • Constantine Tzouanas, MIT, Protein platform perturbing human PBMCs with transcriptomic readout
  • Christine Disteche, University of Washington, Single cell transcriptome analyses of sex differences in normal human development and in genetic conditions with an abnormal number of sex chromosomes
  • April Foster, Wellcome Sanger Institute, Signalling perturbations to understand human development

 

Our collaborators

Logo for Ultima Genomics
Logo for Chan Zuckerberg Initiative
Logo for Nvidia
Logo White

Why Scale up?

Single cell studies are currently limited by expensive technologies or complex experimental workflows. Without the ability to profile high numbers of cells or samples, these studies have limited statistical power to detect true biological signal.

Scale Bio is on a mission to drastically reduce the complexity of highly powered, robust single cell experiments while simultaneously making single cell more affordable to enable groundbreaking research. Now you can amplify atlasing efforts, conduct high-throughput drug screens, perform large cohort studies, power your longitudinal and multi-site studies, and much more.

Close up of scientists hands working in a lab

Some of the many benefits
of submitting your project

Icon of pen and paper

Submissions closed!

The winners have been announced. Check out our press release.

Icon of key in hand

Be the first

Gain early access to the QuantumScale platform which empowers your research and accelerates your single cell discoveries in a whole new way.

Want QuantumScale early access?
Icon of a gear

Transform the way
we approach scientific challenges

From basic research to translational medicine, leave a lasting impact on the field of single cell research and beyond.

Watch the 100 Million Cells and Beyond webcast

Watch this insightful webcast on the groundbreaking 100 Million Cell Challenge. The panel discusses the program’s vision, as well as the types of projects submitted so far and their potential impact on the field. Also, learn how your research can benefit from this unprecedented opportunity and how to submit your proposal.

Inquire about QuantumScale early access